Annual Current Liabilities
$31.13 M
+$12.52 M+67.25%
31 December 2023
Summary:
Celldex Therapeutics annual total current liabilities is currently $31.13 million, with the most recent change of +$12.52 million (+67.25%) on 31 December 2023. During the last 3 years, it has risen by +$16.92 million (+119.10%). CLDX annual current liabilities is now -11.63% below its all-time high of $35.22 million, reached on 31 December 2016.CLDX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$32.09 M
+$4.43 M+16.04%
01 September 2024
Summary:
Celldex Therapeutics quarterly total current liabilities is currently $32.09 million, with the most recent change of +$4.43 million (+16.04%) on 01 September 2024. Over the past year, it has increased by +$4.26 million (+15.29%). CLDX quarterly current liabilities is now -8.89% below its all-time high of $35.22 million, reached on 31 December 2016.CLDX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLDX Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +67.3% | +15.3% |
| 3 y3 years | +119.1% | +126.4% |
| 5 y5 years | +147.0% | +170.0% |
CLDX Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +119.1% | at high | +126.4% |
| 5 y | 5 years | at high | +167.3% | at high | +196.0% |
| alltime | all time | -11.6% | +6125.0% | -8.9% | +6318.6% |
Celldex Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $32.09 M(+16.0%) |
| June 2024 | - | $27.66 M(+5.2%) |
| Mar 2024 | - | $26.29 M(-15.5%) |
| Dec 2023 | $31.13 M(+67.2%) | $31.13 M(+11.8%) |
| Sept 2023 | - | $27.84 M(+77.9%) |
| June 2023 | - | $15.65 M(+2.8%) |
| Mar 2023 | - | $15.22 M(-18.2%) |
| Dec 2022 | $18.61 M(+12.6%) | $18.61 M(+14.3%) |
| Sept 2022 | - | $16.29 M(-45.6%) |
| June 2022 | - | $29.95 M(+105.7%) |
| Mar 2022 | - | $14.56 M(-11.9%) |
| Dec 2021 | $16.53 M(+16.3%) | $16.53 M(+16.6%) |
| Sept 2021 | - | $14.18 M(-2.2%) |
| June 2021 | - | $14.49 M(-14.7%) |
| Mar 2021 | - | $16.98 M(+19.5%) |
| Dec 2020 | $14.21 M(+22.0%) | $14.21 M(+16.4%) |
| Sept 2020 | - | $12.20 M(+12.5%) |
| June 2020 | - | $10.84 M(-0.8%) |
| Mar 2020 | - | $10.93 M(-6.1%) |
| Dec 2019 | $11.64 M(-7.6%) | $11.64 M(-2.1%) |
| Sept 2019 | - | $11.89 M(+3.3%) |
| June 2019 | - | $11.51 M(-4.0%) |
| Mar 2019 | - | $11.99 M(-4.9%) |
| Dec 2018 | $12.60 M(-54.6%) | $12.60 M(-25.2%) |
| Sept 2018 | - | $16.85 M(-15.7%) |
| June 2018 | - | $19.98 M(-16.8%) |
| Mar 2018 | - | $24.01 M(-13.4%) |
| Dec 2017 | $27.74 M(-21.3%) | $27.74 M(+11.3%) |
| Sept 2017 | - | $24.91 M(-13.5%) |
| June 2017 | - | $28.79 M(+6.5%) |
| Mar 2017 | - | $27.02 M(-23.3%) |
| Dec 2016 | $35.22 M(+16.5%) | $35.22 M(+89.1%) |
| Sept 2016 | - | $18.63 M(-6.9%) |
| June 2016 | - | $20.00 M(-21.0%) |
| Mar 2016 | - | $25.31 M(-16.3%) |
| Dec 2015 | $30.24 M(+23.5%) | $30.24 M(+27.9%) |
| Sept 2015 | - | $23.64 M(-11.4%) |
| June 2015 | - | $26.69 M(+26.2%) |
| Mar 2015 | - | $21.15 M(-13.6%) |
| Dec 2014 | $24.49 M(+20.3%) | $24.49 M(+13.3%) |
| Sept 2014 | - | $21.61 M(+1.9%) |
| June 2014 | - | $21.20 M(+8.7%) |
| Mar 2014 | - | $19.51 M(-4.1%) |
| Dec 2013 | $20.35 M(+15.1%) | $20.35 M(+21.2%) |
| Sept 2013 | - | $16.80 M(+34.3%) |
| June 2013 | - | $12.50 M(-31.8%) |
| Mar 2013 | - | $18.33 M(+3.6%) |
| Dec 2012 | $17.68 M(+23.7%) | $17.68 M(+16.9%) |
| Sept 2012 | - | $15.13 M(+20.3%) |
| June 2012 | - | $12.58 M(+0.3%) |
| Mar 2012 | - | $12.55 M(-12.3%) |
| Dec 2011 | $14.30 M(-29.2%) | $14.30 M(+32.7%) |
| Sept 2011 | - | $10.78 M(+3.5%) |
| June 2011 | - | $10.41 M(+16.7%) |
| Mar 2011 | - | $8.92 M(-55.9%) |
| Dec 2010 | $20.21 M(+40.3%) | $20.21 M(-13.2%) |
| Sept 2010 | - | $23.28 M(-1.8%) |
| June 2010 | - | $23.71 M(-4.5%) |
| Mar 2010 | - | $24.82 M(+72.3%) |
| Dec 2009 | $14.41 M(+2.2%) | $14.41 M(+2.1%) |
| Sept 2009 | - | $14.11 M(+9.7%) |
| June 2009 | - | $12.86 M(-8.5%) |
| Mar 2009 | - | $14.05 M(-0.3%) |
| Dec 2008 | $14.10 M(+39.1%) | $14.10 M(-23.5%) |
| Sept 2008 | - | $18.42 M(-8.6%) |
| June 2008 | - | $20.16 M(+75.6%) |
| Mar 2008 | - | $11.48 M(+13.2%) |
| Dec 2007 | $10.14 M(+0.5%) | $10.14 M(+15.7%) |
| Sept 2007 | - | $8.76 M(+3.5%) |
| June 2007 | - | $8.47 M(-17.1%) |
| Mar 2007 | - | $10.21 M(+1.2%) |
| Dec 2006 | $10.08 M | $10.08 M(+22.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2006 | - | $8.23 M(+24.8%) |
| June 2006 | - | $6.60 M(+1.3%) |
| Mar 2006 | - | $6.51 M(+76.4%) |
| Dec 2005 | $3.69 M(-30.2%) | $3.69 M(+3.0%) |
| Sept 2005 | - | $3.59 M(+0.2%) |
| June 2005 | - | $3.58 M(-22.2%) |
| Mar 2005 | - | $4.60 M(-13.1%) |
| Dec 2004 | $5.29 M(+56.3%) | $5.29 M(+38.8%) |
| Sept 2004 | - | $3.81 M(+14.5%) |
| June 2004 | - | $3.33 M(+13.2%) |
| Mar 2004 | - | $2.94 M(-13.1%) |
| Dec 2003 | $3.39 M(-1.4%) | $3.39 M(+6.9%) |
| Sept 2003 | - | $3.17 M(-18.1%) |
| June 2003 | - | $3.86 M(+2.0%) |
| Mar 2003 | - | $3.79 M(+10.4%) |
| Dec 2002 | $3.43 M(-37.8%) | $3.43 M(-5.3%) |
| Sept 2002 | - | $3.62 M(-29.2%) |
| June 2002 | - | $5.11 M(+1.7%) |
| Mar 2002 | - | $5.03 M(-9.0%) |
| Dec 2001 | $5.52 M(+2.3%) | $5.52 M(+11.3%) |
| Sept 2001 | - | $4.96 M(-4.2%) |
| June 2001 | - | $5.18 M(+29.9%) |
| Mar 2001 | - | $3.98 M(-26.2%) |
| Dec 2000 | $5.40 M(+145.3%) | $5.40 M(+74.6%) |
| Sept 2000 | - | $3.09 M(+56.2%) |
| June 2000 | - | $1.98 M(-14.2%) |
| Mar 2000 | - | $2.31 M(+4.9%) |
| Dec 1999 | $2.20 M(-33.3%) | $2.20 M(+10.0%) |
| Sept 1999 | - | $2.00 M(-16.7%) |
| June 1999 | - | $2.40 M(-22.6%) |
| Mar 1999 | - | $3.10 M(-6.1%) |
| Dec 1998 | $3.30 M(+17.9%) | $3.30 M(+17.9%) |
| Sept 1998 | - | $2.80 M(+47.4%) |
| June 1998 | - | $1.90 M(-13.6%) |
| Mar 1998 | - | $2.20 M(-21.4%) |
| Dec 1997 | $2.80 M(+75.0%) | $2.80 M(+21.7%) |
| Sept 1997 | - | $2.30 M(+64.3%) |
| June 1997 | - | $1.40 M(0.0%) |
| Mar 1997 | - | $1.40 M(-12.5%) |
| Dec 1996 | $1.60 M(-33.3%) | $1.60 M(+45.5%) |
| Sept 1996 | - | $1.10 M(-21.4%) |
| June 1996 | - | $1.40 M(-22.2%) |
| Mar 1996 | - | $1.80 M(-25.0%) |
| Dec 1995 | $2.40 M(-7.7%) | $2.40 M(+33.3%) |
| Sept 1995 | - | $1.80 M(-14.3%) |
| June 1995 | - | $2.10 M(-12.5%) |
| Mar 1995 | - | $2.40 M(-7.7%) |
| Dec 1994 | $2.60 M(-23.5%) | $2.60 M(-35.0%) |
| Sept 1994 | - | $4.00 M(+8.1%) |
| June 1994 | - | $3.70 M(0.0%) |
| Mar 1994 | - | $3.70 M(+8.8%) |
| Dec 1993 | $3.40 M(+41.7%) | $3.40 M(+17.2%) |
| Sept 1993 | - | $2.90 M(+16.0%) |
| June 1993 | - | $2.50 M(-7.4%) |
| Mar 1993 | - | $2.70 M(-12.9%) |
| Dec 1992 | $2.40 M(-29.4%) | - |
| Oct 1992 | - | $3.10 M(-8.8%) |
| July 1992 | - | $3.40 M(0.0%) |
| Apr 1992 | - | $3.40 M(+21.4%) |
| Apr 1992 | $3.40 M(+21.4%) | - |
| Jan 1992 | - | $2.80 M(0.0%) |
| Oct 1991 | - | $2.80 M(0.0%) |
| July 1991 | - | $2.80 M(0.0%) |
| Apr 1991 | $2.80 M(+12.0%) | $2.80 M(+33.3%) |
| Jan 1991 | - | $2.10 M(0.0%) |
| Oct 1990 | - | $2.10 M(-32.3%) |
| July 1990 | - | $3.10 M(+24.0%) |
| Apr 1990 | $2.50 M(0.0%) | $2.50 M(+31.6%) |
| Jan 1990 | - | $1.90 M(-24.0%) |
| Apr 1989 | $2.50 M(+92.3%) | $2.50 M(+92.3%) |
| Apr 1988 | $1.30 M(-23.5%) | $1.30 M(-23.5%) |
| Apr 1987 | $1.70 M(+240.0%) | $1.70 M(+240.0%) |
| Apr 1986 | $500.00 K | $500.00 K |
FAQ
- What is Celldex Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Celldex Therapeutics?
- What is Celldex Therapeutics annual current liabilities year-on-year change?
- What is Celldex Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly current liabilities year-on-year change?
What is Celldex Therapeutics annual total current liabilities?
The current annual current liabilities of CLDX is $31.13 M
What is the all time high annual current liabilities for Celldex Therapeutics?
Celldex Therapeutics all-time high annual total current liabilities is $35.22 M
What is Celldex Therapeutics annual current liabilities year-on-year change?
Over the past year, CLDX annual total current liabilities has changed by +$12.52 M (+67.25%)
What is Celldex Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of CLDX is $32.09 M
What is the all time high quarterly current liabilities for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly total current liabilities is $35.22 M
What is Celldex Therapeutics quarterly current liabilities year-on-year change?
Over the past year, CLDX quarterly total current liabilities has changed by +$4.26 M (+15.29%)